Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
about
Urinating standing versus sitting: position is of influence in men with prostate enlargement. A systematic review and meta-analysisCustom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration.Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting.The correlation between the treatment efficacy and the sympathetic activity in men with lower urinary tract symptomsBenign Prostatic Hyperplasia Implications for Pharmacologic Treatment and Perioperative Care.The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms.Safety and feasibility of concomitant surgery during holmium laser enucleation of the prostate (HoLEP).Correlation of prostatic urethral angle with the severity of urinary symptom and peak flow rate in men with small prostate volume.Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis.Towards the prevention and management of prostatic diseases in Nigeria: a framework.Simple Modification of the Bladder Outlet Obstruction Index for Better Prediction of Endoscopically-Proven Prostatic Obstruction: A Preliminary Study.Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort.A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up.Holmium laser enucleation of the prostate: surgical, functional, and quality-of-life outcomes upon extended follow-upRelationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia.Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.The difference of lower urinary tract symptoms between sympathetic hyperactive and hypoactive men.In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in AdulthoodAn overview of prostate diseases and their characteristics specific to Asian men.A prospective study of statin drug use and lower urinary tract symptoms in older men.Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.Nerve growth factor signaling following unilateral pelvic ganglionectomy in the rat ventral prostate is age dependent.Role of interleukins, IGF and stem cells in BPHLow intraprostatic DHT promotes the infiltration of CD8+ T cells in BPH tissues via modulation of CCL5 secretion.The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis.Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review.The role of prostate inflammation and fibrosis in lower urinary tract symptoms.Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.Inhibition of androgen induces autophagy in benign prostate epithelial cells.Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia.Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.Optimizing the management of benign prostatic hyperplasia.The relationship between histological prostatitis and lower urinary tract symptoms and sexual functionInfluence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue.Open suprapubic versus retropubic prostatectomy in the treatment of benign prostatic hyperplasia during resident's learning curve: a randomized controlled trialProstatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms.The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
P2860
Q21090608-469764C7-3F78-4A8E-94C6-76EAFBC2095CQ28547212-091F639A-5FBD-411D-8779-5B691823B327Q33820772-AFAB5963-8553-447F-B735-5C5CC790D814Q34027912-9B948F37-6E41-47FB-97E0-0017C0D50270Q34267513-E76B6569-187E-4679-BCC2-37153EC30BE1Q34338110-401B98CD-ADEF-4AE3-AE10-5223813F8029Q35008649-0DF98769-1606-4A82-A791-612A5F09C2A2Q35087046-3299AE72-C91A-456F-AB31-E52BF3AA3A94Q35225798-1A192D92-95D6-4A16-B349-1ED0B2CEEFFFQ35314832-80B2C5D2-0688-49E8-9001-3A5D9E6C81C8Q35550448-2EDD0F36-3833-46A9-89B0-EAC216187948Q35822544-8510AEBC-6E68-4F6B-BF79-A5B5A40F5AFFQ35883521-E9EF9E80-00F4-47B3-8E0C-6833DC3B0292Q35907713-D95E25D7-BE51-4CE3-9FA6-6A26C88FF643Q36038889-D54F779A-A4EB-4AD4-8F6E-755323A22FB4Q36064535-ADF78BBB-ED7E-4590-BF61-EE93456F8479Q36284900-7E1BB18D-2026-4329-B6BF-8B7FF3E2686FQ36770882-D4057C49-AB9F-479B-B444-E47E868FD4A1Q36987154-2E77E80C-687A-4242-A68F-06BFA6723C90Q37037794-32622EC3-91A5-4C94-AF8A-1B13B46941D5Q37127922-80DE6DFD-AA8D-481A-A589-24DD2834C881Q37269077-53783BED-8ADD-4D79-92B9-AD62FBF41B5EQ37370483-A1E41666-0B5B-44F8-A1CC-5667418584ACQ37416239-697AF672-0F3B-4042-810B-9DEF07FB58B2Q37720293-1560FC56-36CB-4750-AC9F-DB22BBA09068Q38628166-2F43BBE7-ADD5-459E-BD85-0DB586AA5E4AQ38702302-1B664F58-1A82-4838-8FF9-9A8A9B0D5E55Q38903901-52E2C78C-E762-4147-8E50-6910B8765798Q39116956-DC7B1B61-9B8F-419D-A928-C62F220BE5EFQ39131649-3F756199-F6F1-4890-A304-B64850CBD031Q39294665-DFF925F1-DFCA-425C-9B83-6A18F33530A1Q40575194-346D45F1-26E7-47B6-9250-CD13EE9C0E60Q41112355-CAC7C726-0B54-4AE2-94A0-7C0064E59CD4Q41154385-BE78017A-A4C5-422D-A85E-397D4EC47660Q41786747-888BD211-A864-42B2-9201-401DCD656A7EQ41809298-D8324698-97CB-48F2-A774-8262F9222424Q41884137-94266F74-E1B0-4A78-8380-C0200F8FD885Q41897813-996FF7EC-9A1A-4364-9117-3993BD75F9A2Q42051597-E4776E7F-3BB5-433A-A1AF-A8A2B941711EQ42158889-38D420A3-EC86-440B-A954-BFB1F17774F9
P2860
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@en
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@nl
type
label
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@en
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@nl
prefLabel
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@en
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@nl
P1476
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
@en
P2093
Wade Bushman
P304
P356
10.1016/J.UCL.2009.07.003
P577
2009-11-01T00:00:00Z